Holdings of Deep Track Capital, LP
55 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 48 % of the equity sleeve
Sector breakdown
- Industrials 3.3 %
- Unattributed 96.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 96.2 %
- DK 2.2 %
- GB 1.5 %
- FR 0.2 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|
| US | 52 | 4.3B $ | 96.16 % |
| DK | 1 | 98.3M $ | 2.19 % |
| GB | 1 | 67.3M $ | 1.50 % |
| FR | 1 | 6.8M $ | 0.15 % |
Positions
| Company | Shares | Value | Weight |
|---|
| Guardant Health Inc | 3,338,241 | 308.4M $ | |
| Immunovant Inc | 11,526,971 | 286.3M $ | |
| Tarsus Pharmaceuticals Inc | 3,600,000 | 252.5M $ | |
| Vaxcyte Inc | 4,300,000 | 249.9M $ | |
| Structure Therapeutics Inc | 4,279,848 | 206.3M $ | |
| Axsome Therapeutics Inc | 1,100,000 | 185.9M $ | |
| Apellis Pharmaceuticals Inc | 4,532,374 | 182.3M $ | |
| Ocular Therapeutix Inc | 19,686,282 | 166.7M $ | |
| Vera Therapeutics Inc | 4,106,067 | 165.2M $ | |
| Alumis Inc | 6,772,595 | 149.2M $ | |
| Ionis Pharmaceuticals Inc | 1,950,000 | 146.4M $ | |
| Nuvalent Inc | 1,376,324 | 141M $ | |
| CENTESSA PHARMACEUTICALS PLC | 3,158,041 | 125.4M $ | |
| Maze Therapeutics Inc | 3,477,562 | 103.8M $ | |
| Oruka Therapeutics Inc | 2,034,203 | 99.8M $ | |
| Nurix Therapeutics Inc | 6,345,244 | 98.4M $ | |
| Genmab A/S | 3,663,250 | 98.3M $ | |
| Cytokinetics Inc | 1,374,320 | 90.6M $ | |
| GRAIL Inc | 1,722,797 | 89M $ | |
| LB Pharmaceuticals Inc | 3,352,804 | 82.7M $ | |
| MBX Biosciences Inc | 2,757,569 | 82.3M $ | |
| Bicara Therapeutics Inc | 4,062,500 | 80.8M $ | |
| Compass Pathways plc | 12,161,496 | 67.3M $ | |
| BioMarin Pharmaceutical Inc | 1,150,000 | 65M $ | |
| Bridgebio Pharma Inc | 841,445 | 62.5M $ | |
| Immunocore Holdings PLC | 1,931,884 | 58.2M $ | |
| Tango Therapeutics Inc | 2,750,000 | 57.5M $ | |
| Terns Pharmaceuticals Inc | 1,073,877 | 56.6M $ | |
| Geron Corp | 31,720,278 | 47.3M $ | |
| ANI Pharmaceuticals Inc | 600,000 | 46.1M $ | |
| CorMedix Inc | 6,274,076 | 42.6M $ | |
| AtaiBeckley Inc | 12,000,000 | 42.5M $ | |
| Celldex Therapeutics Inc | 1,283,979 | 40.7M $ | |
| Cogent Biosciences Inc | 1,000,000 | 38.5M $ | |
| Corvus Pharmaceuticals Inc | 2,491,539 | 36.5M $ | |
| Dyne Therapeutics Inc | 2,000,000 | 36.3M $ | |
| Soleno Therapeutics Inc | 1,078,710 | 36.1M $ | |
| Aclaris Therapeutics Inc | 9,345,000 | 35M $ | |
| VeraDermics Inc | 500,000 | 31.6M $ | |
| Verastem Inc | 5,740,850 | 30.4M $ | |
| Viridian Therapeutics Inc | 1,393,944 | 27.3M $ | |
| X4 PHARMACEUTICALS INC | 6,339,535 | 26.2M $ | |
| Solid Biosciences Inc | 3,565,062 | 25.7M $ | |
| Enanta Pharmaceuticals Inc | 1,956,867 | 24.7M $ | |
| Apogee Therapeutics Inc | 285,000 | 24M $ | |
| Kura Oncology Inc | 2,643,542 | 21.5M $ | |
| Century Therapeutics Inc | 9,487,745 | 21.4M $ | |
| Beam Therapeutics Inc | 820,765 | 19.6M $ | |
| Context Therapeutics Inc | 7,419,355 | 19.4M $ | |
| Personalis Inc | 3,000,000 | 19.1M $ | |
| Janux Therapeutics Inc | 1,187,290 | 16.5M $ | |
| Inventiva SACA | 1,222,453 | 6.8M $ | |
| Larimar Therapeutics Inc | 1,500,000 | 6.8M $ | |
| Billiontoone Inc | 50,000 | 3.9M $ | |
| Aligos Therapeutics Inc | 444,110 | 3.3M $ | |